University of Delaware
Education & Human Development

Center for Disabilities Studies

Quick Links
  • Quick Links
    • Programs at CDS
    • Contacts at CDS
    • CDS Opportunities
    • Our Annual Report
    • Upcoming Events
    • Close
Make a Gift to the center
  
Make a Gift to the center
Main Menu
  • Home
  • Who We Are
    • Our Mission
    • Our Core Connections
    • Our Funding
    • CDS by the Numbers
    • Our Team
    • Our Advisory Council
    • Support CDS
  • What We Do
    • At a Glance
    • Assistive Technology
    • K-12 Education
    • University Education
    • Transitions to Adulthood
    • Autism Initiatives
    • Health & Wellness
    • Advocacy
  • Publications
    • Our Annual Report
    • Peer-Reviewed Research
    • Book and Chapter Citations
    • Posters and Presentations
    • CDS Reports
    • The delAware
    • AT Messenger
  • Videos & Slideshows
    • About CDS
    • Advocacy
    • Assistive Technology
    • Education
    • Employment
    • Events
    • Health and Wellness
  • Blog
    • Inclusion Blog
  • News
    • From CDS
    • Outside CDS
    • Opportunities at CDS

Prescription Drug Payment Assistance Program

Posted on June 8, 2018

Prescription Drug Payment Assistance Program

An act to amend Titles 16 and 29 of the Delaware Code relating to the restoration of the Delaware Prescription Drug Payment Assistance Program

Synopsis:

Signed: S.B. 228 was signed into law on July 17, 2018 by Gov. John Carney.

Signed: S.B. 228 was signed into law on July 17, 2018 by Gov. John Carney.

This legislation restores the Delaware Drug Payment Assistance Program (DPAP), the Department of Health and Social Services program that has helped people with disabilities and senior citizens afford their medication since 2000. It was cut from the fiscal year 2018 budget as lawmakers struggled to offset a $350 million shortfall from the previous year. DPAP, which cost the state $1.7 million in 2017, will provide as much as $3,000 annually for people who fall below 200 percent of the federal poverty guideline ($24,280 in 2018) or whose prescription costs exceed 40 percent of their annual income. To be eligible, an individual must qualify either for Medicare Part D or federal Old Age, Survivors, Disability Insurance Benefits. In the past several years, DPAP enrollment dwindled as federal programs began offering more generous drug payment assistance. However, when it was cut, DPAP still counted several thousand enrollees who were not eligible for any other assistance.

Sen. David McBride
Sen. David McBride
S.B. 228 lead sponsor

Supporters:

Sens. McBride (D), Poore (D), Marshall (D), Bushweller (D), Ennis (D), Hansen (D), Henry (D), McDowell (D), Pettyjohn (R), Sokola (D), Townsend (D), Walsh (D), Lavelle (R), Richardson (R), Lopez (R), Simpson (R); Reps. Schwartzkopf (D), Heffernan (D), Osienski (D), Kowalko (D), Baumbach (D), Bentz (D), Brady (D), Briggs King (R), Jaques (D), Keeley (D), Matthews (D), Paradee (D), Ramone (R), Williams (D), Bennett (D), Collins (R), Kenton (R), Mitchell (D).

Opponents:

None reported.

Links to Additional Resources:

S.B. 228

News Journal: “Delaware seniors face tough choices as state prescription program ends”

Federal poverty guidelines

Old Age, Survivors, Disability Insurance overview

This entry was posted in and tagged 228, ACA, DPAP, entitlements, Medicare, medication, prescription drugs, sb 228, sb228, Social Security, welfare.

Center for Disabilities Studies

461 Wyoming Road

Newark, DE 19716

Phone: 302-831-6974

TDD: 302-831-4689

UD
  • UD Twitter
  • UD Facebook
  • UD Instagram
  • UD YouTube
  • UD Pinterest
  • UD Linkedin
©2025 University of Delaware
Comments
Legal Notices
Accessibility Notice